In order to clarify intraglomerular cellular activation and cytokine involvement in IgA nephropathy, the glomerular expression of MHC class II antigens (HLA-DR and DQ) and cellular proliferative nuclear antigen (Ki-67), and serum γ-interferon (γ-IFN) levels were evaluated in 49 patients with IgA nepropathy. HLA-DR was detected in all but 4 patients in whom glomerular sclerosis was present. HLA-DQ and Ki-67 were observed in 51 and 38% of the patients, respectively. Proteinuria, recent macroscopic hematuria, mesangial proliferation, and extracapillary and endocapillary lesions were more frequent and more severe in HLA-DQ-positive than in HLA-DQ-negative patients. In 10 patients with acute exacerbation, endocapillary lesions and HLA-DQ and Ki-67 expression were present in 70,80 and 88%, respectively. Serum γ-IFN levels were high in the patients (2.0 ± 0.3 U/ml, n = 40), especially during acute exacerbation (3.4 ± 1.1 U/ml, n = 9). Glomerular HLA-DQ and Ki-67 expression correlated with serum γ-IFN levels (r = 0.73, p < 0.01 for HLA-DQ; r = 0.75, p < 0.01 for Ki-67). Renal biopsy specimens taken before and after prednisolone and/or urokinase therapy were available from 4 patients. There was strong reactivity to HLA-DQ in the glomerular tufts of all 4 pretreatment samples. However, HLA-DQ reactivity disappeared after treatment in 3 samples, concomitant with normalization of serum γ-IFN levels. We conclude that serum γ-IFN levels are related to glomerualr HLA-DQ and Ki-67 expression and acute exacerbation in patients with IgA nephropathy. These data suggest that γ-IFN and MHC class II antigens play an important role in the immune-mediated glomerular injury of IgA nephropathy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.